The world feels more unpredictable than ever. Economies around the globe are reeling from new U.S. tariff policies, military ...

Neurophet, a Korean brain imaging software firm, is making a high-stakes bet on Alzheimer’s, and it’s counting on Eli Lilly ...

Huons Group held a ceremony Friday at its headquarters in Pangyo, Seongnam, Gyeonggi Province, to commemorate the company’s ...

Four risk factors increase the risk of developing stomach cancer, one of the most common cancers in Korea. These are ...

Konyang University Hospital has partnered with Japan's National Institutes for Quantum Science and Technology (QST) to study ...

Astellas Korea will reapply for health insurance coverage for its new drug Vyloy (zolbetuximab), a targeted treatment for ...

A medical society has recommended expanding national mandatory vaccinations for major infectious diseases that threaten the ...

Yuhan Corp. is exploring various collaborative strategies to develop new obesity drugs. In addition to securing the ...

Rhythm Pharmaceuticals, a U.S. company that bought a global license from LG Chem for its oral orphan obesity drug Bivamelagon ...

GC Genome said it presented clinical research validating the early pancreatic cancer prediction performance of its ...

The Ministry of Health and Welfare has announced its intention to revise the anatomy education curriculum in medical schools ...

Korea's Lotte Biologics is stacking up its antibody-drug conjugate (ADC) partnerships, this time tapping AbTis, Dong-A ST’s ...